PACCX | VASIX | PACCX / VASIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 30 years | - |
Gain YTD | 9.399 | 4.486 | 210% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 576M | 3.97B | 15% |
Annual Yield % from dividends | 1.52 | 3.30 | 46% |
Returns for 1 year | 15.85 | 10.03 | 158% |
Returns for 3 years | -5.05 | -4.43 | 114% |
Returns for 5 years | 7.17 | 6.04 | 119% |
Returns for 10 years | 6.67 | 27.27 | 24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBICX | 8.26 | 0.04 | +0.49% |
ClearBridge International Value C | |||
JLVIX | 81.40 | N/A | N/A |
JHancock Fundamental Large Cap Core I | |||
FIZRX | 40.03 | N/A | N/A |
Delaware Opportunity R | |||
SAPEX | 18.14 | -0.11 | -0.60% |
Spectrum Active Advantage Investor | |||
ETIHX | 35.66 | -0.84 | -2.30% |
Eventide Healthcare & Life Sciences I |